Vebreltinib
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Vebreltinib, covering 2024-10-16 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC [Phase 2]